Cresco Labs Debuts New Dispensary in Tamarac, Florida
New Sunnyside location enhances patient access in Broward County
Cresco Labs has opened its 31st Florida dispensary, a Sunnyside location in Tamarac at 6001 N University Drive, as the company continues expanding in one of the nation's largest medical cannabis markets.
Florida has over 750,000 registered medical marijuana patients, making it the third-largest medical cannabis market in the U.S. after California and Oklahoma. The state does not allow recreational sales.
"Our expansion in Florida is a testament to our commitment to providing quality cannabis products and enhancing patient accessibility," said Charles Bachtell, Cresco Labs CEO.
Florida's Medical Market
The state's medical program, approved by voters in 2016, has grown rapidly. Qualifying conditions include cancer, epilepsy, glaucoma, HIV/AIDS, PTSD, ALS, Crohn's disease, Parkinson's disease, and multiple sclerosis, among others.
Patients must obtain a physician recommendation and register with the state's medical marijuana use registry. Once approved, they can purchase products from licensed dispensaries like Sunnyside.
The Tamarac location is Cresco's 72nd dispensary nationwide. The company operates in multiple states including Illinois, Pennsylvania, Ohio, and Massachusetts, though Florida represents one of its largest retail footprints.
Competitive Landscape
Florida's medical cannabis market includes major multi-state operators like Trulieve, which dominates with over 120 locations statewide, as well as Curaleaf, Verano, and AYR Wellness.
The competitive environment has driven innovation in products and services. Dispensaries offer delivery, online ordering, rewards programs, and educational resources to attract and retain patients.
Cresco's Sunnyside brand focuses on customer experience and product quality. The company manufactures many of its own products, giving it control over the supply chain from cultivation through retail.
Market Outlook
Florida voters will decide on a recreational cannabis ballot initiative in 2024. If approved, the market would expand significantly, though existing medical operators would have a head start in serving adult-use customers.
For now, companies like Cresco continue building their medical market presence in anticipation of potential future expansion.
This article is based on original reporting by Financial Post.
Original Source
This article is based on reporting from Financial Post.
Read the original articleOriginal title: "Cresco Labs Opens Sunnyside Tamarac, Expanding Patient Access in Broward County, Florida"
Related Topics
Related Stories
Industry NewsNew York Recalls Cannabis Products After Lab Issues False Results
New York regulators ordered a recall of adult-use cannabis products after an investigation found a state-licensed testing lab issued unreliable results over a two-month period.
Industry NewsNYCRA's Brooklyn Summit Returns March 13 for Fourth Year
The New York Cannabis Retail Association returns to Brooklyn March 13 for its fourth annual industry gathering, connecting retailers and brands as the state's legal market faces ongoing challenges.
InternationalEurope's Medical Cannabis Imports Surge as U.S. Rescheduling Looms
Germany's medical cannabis imports are surging as Europe builds pharmaceutical-based programs while U.S. operators await federal rescheduling decisions that may carry more symbolic than practical weight internationally.
More from Alex Morgan
View all articles
Bob Weir's Nuanced Cannabis Stance Defied 'Drug Band' Stereotypes
Rescheduling Won't Fix Cannabis Industry Without Insurance Access
Chicago's Cannabis Run Club Grows From 'Highdea' to Weekly Tradition
